Pharmafile Logo
Pharmafocus logo
Advanced Search

Lockdown

Showing 4 posts of 4 posts found.

Summer COVID cases set to reach 2 million with 10 million isolating

July 7, 2021
Research and Development COVID-19, Lockdown, UK, Vaccine, government

Analysis from the Guardian has found that over two million people could contract COVID-19 this summer, which could therefore lead …

News
800px-informal_meeting_of_ministers_for_foreign_affairs_gymnich

Gatherings of over six people to be banned in England from Monday

September 9, 2020
Research and Development Lockdown, coronavirus

England is set to increase lockdown restrictions across the country after a surge in coronavirus cases.  Currently, most outdoor gatherings …

News
xockdown

UK lockdown caused infection ‘R’ rate to drop as low as 0.57, according to a new study

July 15, 2020
Research and Development COVID, COVID-19, Lockdown, coronavirus

A new study showed that the coronavirus infection rate hit its lowest point one month before lockdown restrictions were lifted. …

News
desantis

More than half of US states will relax lockdowns by the end of the week

April 30, 2020
Business Services COVID-19, Lockdown, coronavirus, quaratine

Nearly half of US states will have their ‘stay-at-home’ orders expire this week, paving the way for much of the …

News

Latest content

Sanofi shares results from phase 2 trial for frexalimab in MS treatment

July 1, 2024

EMA accepts AstraZeneca’s regulatory submission for sipavibart for COVID-19 prevention

July 1, 2024

Eisai and Biogen’s Leqembi launched for Alzheimer’s treatment in China

June 28, 2024

AbbVie’s Tepkinly gains positive CHMP opinion for follicular lymphoma treatment

June 28, 2024

IDEAYA Biosciences announces first-patient-in for phase 1 clinical trial evaluating IDE397 and Trodelvy combination in MTAP-deletion bladder cancer

June 27, 2024